EdiGene

Q: What industry does EdiGene belong to?

EdiGene is in the industry of: Business Services , Research & Development

Business Services · China · 51-200 Employees

View Company Info for Free

Overview

Headquarters

Building 2 22 Science Park Road Zhonggua...

Phone Number

+86 1080733899

Website

www.edigene.com

Revenue

$29.6 Million

Industry

Business Services

Research & Development

ZI Rank: 1

Signal Type

Feb

Mar

Apr

May

Jun

Jul

ZI Rank

About EdiGene

EdiGene is a clinical-stage biotechnology company focused on leveraging the cutting-edge genome editing technologies to accelerate drug discovery and develop novel therapeutics for a broad range of genetic diseases and cancer. Established in 2015, EdiGene is headquartered in Beijing, China.Explore more

Is this data correct?

View contact profiles from EdiGene

Popular Searchesedigene IncEdigeneEdiGene - CorpEdiGene Biotechnology USAEdiGene Biotechnology USA IncSIC Code 87,873NAICS Code 54,541Show more

EdiGene Org Chart

Phone

Yajun Si

Chief Operations Officer

Phone

Get the full picture

Jay Liu

Vice President, Program Management

Phone

Get the full picture

Is EdiGene your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Last 7 days

Click to see if EdiGene had a recent Job posting/layoffs

Competitive Alert! Recent activity has been detected by your competitor Masked Content

EdiGene, which may be a good buyer, showed buying intent in Masked Content Topic

Funding: Get notified immidiatlly once EdiGene has new funding data

Earning: See what the market has to say on EdiGene recently announced quarterly report

Congratulate Masked Content for being promoted to Masked Content at EdiGene

Check if EdiGene has recently received funding, and reach out quickly before it becomes old news!

Check out if EdiGene is spiking on competitors!

Website visits: Recent activity has been detected on your website

Product Launch: Get notified when EdiGene launches new products

Recommended Actions

Reach out to Masked Content who joined EdiGene as Masked Content

Find 2 more new buyers

View Email Formats for EdiGene

Among all Business Services companies

Low Activity

High Activity

Activity Insights

EdiGene is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

EdiGene is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about EdiGene.

EdiGene financials insights

Gather financial insights about EdiGene, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2018

Series A

$14.5M

2019

Other Financing Round

$11M

2021

Series B

$129M

See All EdiGene's Financials Insights

EdiGene Tech Stack

A closer look at the technologies used by EdiGene

See more technologies

Most Recent Scoops

Facilities Relocation / Expansion

EdiGene is planning to move its offices in July 2022. The move will impact employees at their existing office located at R&D Center, 2A, Cambridge, MA.

Facilities Relocation/Expansion

Funding

, a biotechnology company, has secured $62 million in additional Series B funding, bringing the round’s total to $129 million. Loyal Valley Capital led the round, with contributions from BioTrack Capital, Sherpa Healthcare Partners, and other previous investors.

Funding

, a biotechnology company specializing in genome editing, has secured $67 million in Series B funding. The round was led by 3H Health Investment, with participation from Sequoia Capital China, Alwin Capital, Kunlun Capital, and existing investors.

Funding

Partnership

EdiGene has partnered with Immunochina in a research and development collaboration to develop allogeneic CAR-T therapies for cancer treatment.

Funding

See more scoops